Your browser doesn't support javascript.
Changes in notifiable infectious disease incidence in China during the COVID-19 pandemic.
Geng, Meng-Jie; Zhang, Hai-Yang; Yu, Lin-Jie; Lv, Chen-Long; Wang, Tao; Che, Tian-Le; Xu, Qiang; Jiang, Bao-Gui; Chen, Jin-Jin; Hay, Simon I; Li, Zhong-Jie; Gao, George F; Wang, Li-Ping; Yang, Yang; Fang, Li-Qun; Liu, Wei.
  • Geng MJ; Division of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Zhang HY; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, P. R. China.
  • Yu LJ; Center for Disease Control and Prevention of Central Theater Command, Shijingshan District, Beijing, China.
  • Lv CL; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, P. R. China.
  • Wang T; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, P. R. China.
  • Che TL; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, P. R. China.
  • Xu Q; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, P. R. China.
  • Jiang BG; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, P. R. China.
  • Chen JJ; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, P. R. China.
  • Hay SI; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, P. R. China.
  • Li ZJ; Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, WA, USA.
  • Gao GF; Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
  • Wang LP; Division of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Yang Y; Division of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Fang LQ; Division of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China. wanglp@chinacdc.cn.
  • Liu W; Department of Biostatistics, College of Public Health and Health Professions, and Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA. yangyang@ufl.edu.
Nat Commun ; 12(1): 6923, 2021 11 26.
Article in English | MEDLINE | ID: covidwho-1537314
ABSTRACT
Nationwide nonpharmaceutical interventions (NPIs) have been effective at mitigating the spread of the novel coronavirus disease (COVID-19), but their broad impact on other diseases remains under-investigated. Here we report an ecological analysis comparing the incidence of 31 major notifiable infectious diseases in China in 2020 to the average level during 2014-2019, controlling for temporal phases defined by NPI intensity levels. Respiratory diseases and gastrointestinal or enteroviral diseases declined more than sexually transmitted or bloodborne diseases and vector-borne or zoonotic diseases. Early pandemic phases with more stringent NPIs were associated with greater reductions in disease incidence. Non-respiratory diseases, such as hand, foot and mouth disease, rebounded substantially towards the end of the year 2020 as the NPIs were relaxed. Statistical modeling analyses confirm that strong NPIs were associated with a broad mitigation effect on communicable diseases, but resurgence of non-respiratory diseases should be expected when the NPIs, especially restrictions of human movement and gathering, become less stringent.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Communicable Diseases / Disease Notification Type of study: Observational study Limits: Humans Country/Region as subject: Asia Language: English Journal: Nat Commun Journal subject: Biology / Science Year: 2021 Document Type: Article Affiliation country: S41467-021-27292-7

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Communicable Diseases / Disease Notification Type of study: Observational study Limits: Humans Country/Region as subject: Asia Language: English Journal: Nat Commun Journal subject: Biology / Science Year: 2021 Document Type: Article Affiliation country: S41467-021-27292-7